The tolerability gap may be less significant in practice than the raw nausea percentages suggest
Therapy with a 5-reductase inhibitor markedly reduces the DHT content of the prostate and, in turn, reduces prostate volume and BPH symptoms
This method bypasses the digestive system, making it ideal for people who: Have trouble absorbing B12 due to gastrointestinal issues (like Crohns disease or coeliac disease) Are on medications that interfere with B12 absorption (like metformin or anti-acids) Follow vegan or vegetarian diets Have undergone gastric surgery
Furthermore, the levels of 5MTHF in the CSF are extremely low or even unmeasurable in this group of patients
L-glutamine (510g daily) is the primary fuel for intestinal epithelial regeneration
Neuroprotection: Preliminary studies indicate GHK-Cu may have neuroprotective properties, with potential relevance to neurodegenerative conditions through its anti-inflammatory and antioxidant mechanisms